abstract |
The present invention is directed to novel bicyclic triazolopyrimidine compounds of Formula (I) or a form thereof: n nwherein X 1 , X 2 , R 1 , R 2 , R 3 and R 4 are as defined herein, and their methods of preparation and use as ADP inhibitors. |